Ayala Pharmaceuticals, Inc. (ADXS)
OTCMKTS
· Delayed Price · Currency is USD
0.0271
+0.0001 (0.19%)
Dec 5, 2024, 3:57 PM EST
Ayala Pharmaceuticals Employees
As of December 31, 2023, Ayala Pharmaceuticals had 21 total employees, including 20 full-time and 1 part-time employees.
Employees
21
Change
n/a
Growth
n/a
Revenue / Employee
$619
Profits / Employee
-$2,289,143
Market Cap
1.33M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 21 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sandoz Group AG | 22,633 |
| Telix Pharmaceuticals Limited | 234 |
| Elekta AB (publ) | 4,718 |
| Ryman Healthcare Limited | 7,700 |
| Verano Holdings Corp. | 3,900 |
| Vireo Growth Inc. | 490 |
| Medexus Pharmaceuticals Inc. | 82 |
Ayala Pharmaceuticals News
- 7 months ago - Ayala Pharmaceuticals Files Form 15 to Voluntarily Deregister and Suspend its Reporting Obligations - GlobeNewsWire
- 9 months ago - Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome - GlobeNewsWire
- 10 months ago - Immunome Recognizes Ayala Pharmaceuticals' Announced Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors - Business Wire
- 10 months ago - Immunome to Acquire AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals - Business Wire
- 1 year ago - Ayala Pharmaceuticals Presents Updated AL102 Results from Phase 2 Clinical Trial in Desmoid Tumors at ESMO Congress 2023 - GlobeNewsWire
- 1 year ago - Ayala Pharmaceuticals Announces Closing of Merger with Biosight - GlobeNewsWire
- 1 year ago - Ayala Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 1 year ago - Ayala Pharmaceuticals Announces Abstracts on AL102 and AL101 Accepted for Presentation at ESMO Congress 2023 - GlobeNewsWire